[2010, amended 2019] 1.5.22 Offer all women who have had pre-eclampsia a medical review with their GP or specialist 6 8 weeks after the birth. [2010, amended 2019] Haematological and biochemical monitoring 1.5.23 In women who have pre-eclampsia with mild or moderate hypertension, or after step-down from critical care: measure platelet count, transaminases and serum creatinine 48 72 hours after birth or step-down do not repeat platelet count, transaminases or serum creatinine measurements if results are normal at 48 72 hours. [2010] 1.5.24 If biochemical and haematological indices are outside the reference range in women with pre-eclampsia who have given birth, repeat platelet count, transaminases and serum creatinine measurements as clinically indicated until results return to normal. [2010, amended 2019] 1.5.25 In women with pre-eclampsia who have given birth, carry out a urinary reagent-strip test 6 8 weeks after the birth. [2010] 1.5.26 Offer women who had pre-eclampsia and still have proteinuria (1+ or more) at 6 8 weeks after the birth, a further review with their GP or specialist at 3 months after the birth to assess kidney function. [2010, 1.5.27 Consider referring women with an abnormal kidney function assessment at 3 months for a specialist kidney assessment in line with the NICE guideline on chronic kidney disease. [2010, amended 2019] 1.6 Fetal monitoring Fetal monitoring in chronic hypertension 1.6.1 In women with chronic hypertension, carry out an ultrasound for fetal growth and amniotic fluid volume assessment, and umbilical artery doppler velocimetry at 28 weeks, 32 weeks and 36 weeks. [2010, 1.6.2 In women with chronic hypertension, only carry out cardiotocography if clinically indicated. 